Learn to avoid common communication errors by understanding overgeneralisation in verbal adjectives, the subjunctive mood, ...
Primarily known as an immunology and neuroscience company, AbbVie wanted to put the biopharma world on notice during its J.P.
The first two days of the J.P. Morgan Healthcare Conference are in the books, and attendees are now pushing through to finish ...
After a busy first day featuring headlines from a who's who of leading biopharma companies, the J.P. | The J.P. Morgan ...
Press Release New Investments HAS Healthcare Advanced Synthesis SA Group Announces Strategic Investment Plan to Strengthen ...
Smiley also details how Zai Lab blends China’s development speed capabilities with global clinical and regulatory standards, ...
Discover the top 3 manufacturing mistakes CDMOs make and how to prevent them when scaling for next-generation oncology.
Zacks Investment Research on MSN
Exelixis posts preliminary '25 results, issues '26 outlook
Exelixis, Inc. EXEL reported preliminary, unaudited financial results for fiscal year 2025, issued financial guidance for ...
In the past three weeks, a flurry of licensing deals with Chinese biotechs were announced featuring AbbVie, AstraZeneca, ...
Dual-payload ADCs are gaining traction, offering opportunities to overcome the tumour heterogeneity and resistance challenges faced by conventional ADCs.
As rulemaking proceeds and lawmakers convene for the 2026 Legislative Session, Florida Families for Vaccines plans to engage ...
As of Tuesday, January 13, Ligand Pharmaceuticals Incorporated’s LGND share price has dipped by 7.83%, which has investors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results